Fiscal Year 2022 Fourth Quarter Highlights Net sales of $87.0 million increased 13.2% compared to the prior-year quarter Gross margin of 53.4% declined 170 basis points year over year GAAP loss per share of $0.16 and adjusted earnings per share of $0.01 Cash and cash equivalents at May 31, 2022 were $28.8 million Full-Year 2022 … [Read more…]
STAFFORD, Texas–(BUSINESS WIRE)–Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, announced that the Food and Drug Administration (FDA) has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed. As previously announced, the Phase III clinical trial was placed on clinical hold by … [Read more…]
EVERETT, Wash.–(BUSINESS WIRE)–Fluke Biomedical announced the OneQA test and workflow automation software now supports the top-selling ProSim 8 multifunction patient simulator. Fluke Biomedical OneQA is an industry-leading quality assurance software platform that helps hospitals, independent service organizations and OEM service teams increase the safety, efficiency, and accuracy of medical equipment testing and quality assurance workflows. … [Read more…]
– $55 million Series A financing will advance the company’s robust preclinical pipeline and ongoing discovery efforts – – Epic holds exclusive license to smallest known Cas protein, enabling in vivo delivery via AAV vector to wide range of target organs – – Lead program in facioscapulohumeral muscular dystrophy (FSHD) on track for clinical initiation … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “NGS Oncology Market – A Global and Regional Analysis: Focus on Offering, Sequencing Technology, Workflow, Application, End User, and Region – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. Global NGS Oncology Market Industry Overview The global NGS oncology market is projected to reach $51,783.0 million in 2032 from 14,828.6 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Hematologic Malignancies Testing Market: Focus on Hematologic Malignancies Testing Product and Application, Supply Chain Analysis, and Country Analysis – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. Hematologic Malignancies Testing Market: Industry Overview The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from … [Read more…]
Novel Vaccine Company Expands Leadership Team and Establishes US Presence OXFORD, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–SpyBiotech, a British biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Mark Leuchtenberger as its Chief Executive Officer (CEO). He also joins the Board of Directors. Sumi Biswas, the … [Read more…]
Dr Jennifer Schneider appointed CEO, Dr Helen Bright joins as VP of Research & Development, and Professor David Roblin will Chair the Board of Directors Senior appointments support acceleration of novel immunotherapies to treat infectious disease, leveraging the Alphamer platform Team expansion follows recent £24m investment from Boehringer Ingelheim Venture Fund, Evotec SE and Novo … [Read more…]
LONDON–(BUSINESS WIRE)–Ixaka Ltd, an integrated cell and gene therapy company focused on boosting the natural power of the body to cure disease, today announces the appointment of Dr Karen Miller as Chief Scientific Officer. Karen joins Ixaka bringing more than 30 years of experience in the biotech and pharma industry, leading drug discovery, preclinical and … [Read more…]
TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial areas. As Director of Sales & Marketing at AMICOGEN, a leading manufacturer … [Read more…]
